Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Clinical and Translational Allergy
|
October 28, 2021
Effectiveness of mepolizumab in severe asthma in Japan: A real-world study using claims data
Hiroyuki Nagase, Jun Tamaoki, Takeo Suzuki, et al.
Blood Neoplasia
|
June 2, 2025
Real-world treatment patterns and clinical outcomes in patients with follicular lymphoma: a SEER-Medicare analysis
Dai Chihara, Shibing Yang, Savreet Bains Chawla, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
December 24, 2021
Real-life effectiveness of mepolizumab in severe asthma: a systematic literature review
Elliot Israel, Giorgio Walter Canonica, Guy Brusselle, et al.
Pulmonary Pharmacology & Therapeutics
|
June 17, 2022
Reduction in asthma exacerbation rate after mepolizumab treatment initiation in patients with severe asthma: A real-world database study in Japan
Hiroyuki Nagase, Jun Tamaoki, Takeo Suzuki, et al.
Future Oncology (London, England)
|
September 13, 2024
Logistical challenges of CAR T-cell therapy in non-Hodgkin lymphoma: a survey of healthcare professionals
Anna Sureda, Shiraz El Adam, Shibing Yang, et al.
OTO Open
|
October 17, 2022
Elucidating the Real-World Burden of Chronic Rhinosinusitis With Nasal Polyps in Patients in the USA
Victoria S Benson, Guillaume Germain, Robert H Chan, et al.
The European Respiratory Journal
|
August 21, 2020
Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis
Tim Harrison, Giorgio Walter Canonica, Geoffrey Chupp, et al.
Journal of Hematology & Oncology
|
August 16, 2024
Comparisons of treatment outcomes of epcoritamab versus chemoimmunotherapy, polatuzumab-based regimens, tafasitamab-based regimens, or chimeric antigen receptor T-cell therapy, in third-line or later relapsed/refractory large B-cell lymphoma
Allison Rosenthal, Javier Munoz, Monika Jun, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
April 10, 2022
Evaluating enrollment and outcome criteria in trials of biologics for chronic rhinosinusitis with nasal polyps
Larry Borish, Noam A Cohen, Geoffrey Chupp, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Clinical and Translational Allergy
|
October 28, 2021
Effectiveness of mepolizumab in severe asthma in Japan: A real-world study using claims data
Hiroyuki Nagase, Jun Tamaoki, Takeo Suzuki, et al.
Blood Neoplasia
|
June 2, 2025
Real-world treatment patterns and clinical outcomes in patients with follicular lymphoma: a SEER-Medicare analysis
Dai Chihara, Shibing Yang, Savreet Bains Chawla, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
December 24, 2021
Real-life effectiveness of mepolizumab in severe asthma: a systematic literature review
Elliot Israel, Giorgio Walter Canonica, Guy Brusselle, et al.
Pulmonary Pharmacology & Therapeutics
|
June 17, 2022
Reduction in asthma exacerbation rate after mepolizumab treatment initiation in patients with severe asthma: A real-world database study in Japan
Hiroyuki Nagase, Jun Tamaoki, Takeo Suzuki, et al.
Future Oncology (London, England)
|
September 13, 2024
Logistical challenges of CAR T-cell therapy in non-Hodgkin lymphoma: a survey of healthcare professionals
Anna Sureda, Shiraz El Adam, Shibing Yang, et al.
OTO Open
|
October 17, 2022
Elucidating the Real-World Burden of Chronic Rhinosinusitis With Nasal Polyps in Patients in the USA
Victoria S Benson, Guillaume Germain, Robert H Chan, et al.
The European Respiratory Journal
|
August 21, 2020
Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis
Tim Harrison, Giorgio Walter Canonica, Geoffrey Chupp, et al.
Journal of Hematology & Oncology
|
August 16, 2024
Comparisons of treatment outcomes of epcoritamab versus chemoimmunotherapy, polatuzumab-based regimens, tafasitamab-based regimens, or chimeric antigen receptor T-cell therapy, in third-line or later relapsed/refractory large B-cell lymphoma
Allison Rosenthal, Javier Munoz, Monika Jun, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
April 10, 2022
Evaluating enrollment and outcome criteria in trials of biologics for chronic rhinosinusitis with nasal polyps
Larry Borish, Noam A Cohen, Geoffrey Chupp, et al.
Page
of 3